Alkermes, Inc.
Alkermes, Inc., a prominent biopharmaceutical company headquartered in the United States, focuses on developing innovative therapies for central nervous system (CNS) disorders and addiction. Founded in 1987, Alkermes has established itself as a leader in the industry, with significant operational presence across North America and Europe. The company is renowned for its unique drug delivery technologies and a robust portfolio of products, including treatments for schizophrenia, depression, and opioid dependence. Alkermes' commitment to addressing complex medical needs has positioned it favourably in the market, with notable achievements in advancing patient care through its proprietary formulations. With a strong emphasis on research and development, Alkermes continues to drive innovation in the biopharmaceutical landscape.
DitchCarbon Score
How does Alkermes, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Alkermes, Inc.'s score of 25 is lower than 62% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Alkermes, Inc.'s reported carbon emissions
In 2017, Alkermes, Inc. reported significant emissions data, with Scope 1 and 2 emissions per employee at approximately 125,000 kg CO2e. This figure reflects the company's operational impact on climate change. The previous year, 2016, saw a slightly higher emissions per employee figure of about 140,000 kg CO2e, while in 2015, it was around 179,000 kg CO2e. This indicates a trend of decreasing emissions intensity over the years. Despite these figures, Alkermes has not disclosed specific reduction targets or initiatives aimed at further decreasing their carbon footprint. The absence of documented climate pledges or Science Based Targets Initiative (SBTi) commitments suggests that while the company is aware of its emissions, it may not have formalised strategies in place to address climate change comprehensively. Overall, Alkermes, headquartered in the US, demonstrates a commitment to monitoring its emissions, but further transparency regarding reduction strategies and climate commitments would enhance its sustainability profile.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Alkermes, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
